Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 130 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Axicabtagene ciloleucel IV for relapsed/refractory acute lymphoblastic leukaemia in children and adolecents (aged 2-21 years) – second line	Brexucabtagene autoleucel (Tecartus; KTE-X19)	Acute lymphoblastic leukaemia (ALL)	Haematological Cancer and Lymphomas	2017	View \| Download
Avelumab for gastric and gastroesophageal junction adenocarcinoma – third line	Avelumab (Bavencio; MSB-0010718C)	Gastric cancer , Gastro-oesophageal junction cancer	Gastrointestinal Cancer	2017	View \| Download
Atezolizumab (Tecentriq) and Cobimetinib (Cotellic) for advanced/metastatic colorectal cancer - third line	Atezolizumab (Tecentriq; MPDL3280A) , Cobimetinib (Cotellic; GDC-0973; cobimetinib hemifumarate)	Colorectal cancer	Gastrointestinal Cancer , Oncology	2017	View \| Download
Asinercept (Apocept) for glioblastoma multiforme for first or second line	Asunercept (Apocept; APG101)	Glioma	Neurological Cancer	2017	View \| Download
Arimoclomol for Niemann-Pick Disease type C - add-on therapy	Arimoclomol (BRX-345)	Niemann-Pick Disease	Endocrine Nutritional and Metabolic Disorders , Genetic Disorders , Neurology	2017	View \| Download
AR101 peanut allergy immunotherapy for adult and paediatric patients	Palforzia (AR101)	Peanut allergy	Immunology	2017	View \| Download
ALXN 1210 for Paroxysmal Nocturnal Haemoglobinuria – First Line	Ravulizumab (ALXN1210; Ultomiris)	Paroxysmal nocturnal haemoglobinuria (PNH)	Haematology	2017	View \| Download
Alpelisib in Combination with Fulvestrant for Advanced HR Positive, HER2-negative Breast Cancer in Men and Postmenopausal Women	Alpelisib (BYL719; Piqray) , Fulvestrant (Faslodex)	Breast cancer	Breast Cancer	2017	View \| Download
Abemaciclib in combination with fulvestrant for advanced or metastatic breast cancer after prior endocrine therapy	Abemaciclib (LY2835219; Verzenio; CC-115) , Fulvestrant (Faslodex)	Breast cancer	Breast Cancer	2017	View \| Download
A4250 for progressive familial intrahepatic cholestasis	Odevixibat (A4250)	Progressive familial intrahepatic cholestasis (PFIC)	Genetic Disorders , Hepatology	2017	View \| Download